Clinical Trials Sponsored by Hatice Gul OZTAS
Total 1 results
-
Hatice Gul OZTASCompletedBreast Feeding | Self EfficacyTurkey
Sponsors and Collaborators
- Sublimity Therapeutics Holdco Limited
- The Australia-Israel Scientific Exchange Foundation (AISEF)
- Centro Universitário Franciscano
- Bassam Abdulkarim
- IRCCS Istituto Auxologico Italiano, Milano, Italy
- Etan Orgel
- Åke Wibergs Stiftelse
- ECMC
- Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
- Hospitales Universitarios Virgen del Rocío
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- the people hospital of Linzhi
- Daniela Pacella - University of Naples Federico II, Naples
- Dr Philippe METELLUS
- National Institute of Cardiovascular Diseases, Bangladesh
- AlpinARC
- ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
- Glasgow Western Infirmary
- Sahachat Aueyingsak
- Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
- View Full List
Medical Conditions
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
- Degenerative Spondylolisthesis G1
- Value-Based Health Insurance
- Ability to Swim 100m Independent Freestyle
- Patients With Leptomeningeal Disease
- Interviews
- Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
- Progression to PD-1 Antibody
- Initiation of Depo-Provera (DMPA)
- Adult Patients Undergoing Surgery That Requires General Anesthesia
- Eosinophil Blood Count
- Genetic Risk Factor
- Legal History
- Pancreaticoduodenectomy
- Orthopaedic Disorders
- Transitional Cell Carcinoma of Renal Pelvis
- Hyperprolinemia
- Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
- Panniculectomy
- Bladder Cancer TNM Staging Primary Tumor (T) T2B
- View Full List
Drug Interventions
- Epirubicin hydrochloride
- Erythropoietin
- Antibiotic treatment
- Metoclopramide + dexamethasone
- 6% hetastarch
- UFUR and Iressa
- Injectable Insulin
- 0% N2O
- Omeprazole 20mg
- ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
- Paliperidone palmitate
- ASP8062
- Prasugrel
- 5-Fluoro-uracil
- IV rtPA (intravenous recombinant plasminogen activator)
- Mepivacaine
- HBM4003 and Triprilimab
- Cefuroxime 750mg oral
- Gefitinib
- Nimotuzumab
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Burundi
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Georgia
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Iran
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Philippines
- Contract Research Organizations in Poland
- Contract Research Organizations in Senegal
- Contract Research Organizations in United Arab Emirates
- CRO list by country